ArcSight -- Approac...
Health Care: Drugs
Abbott Laboratories (ABT: NYSE)
$50.74 0.13 | 0.26%
09/03/10 - 04:04 PM ET
4.78M / 7.40M
Vol / Avg. Vol:50.99 / 50.61
Open / Prev. Close:50.25 - 50.99
Today's Range:44.59 - 56.79
52 Wk Range:-6.02%
Performance YTD:TheStreet Rating:
Portfolios with ABT
- Portfolio NameUser Type
- ContributorCramer's Bounce-Back-Begins...
- ContributorCharts Of The Week 5-19-2010
- ContributorCramer's Crisis Stock Buys
- ContributorCramer's Stocks You Can Fig...
- ContributorFast Money's Battle The Bea...
- ContributorCramer's Top Stocks Followi...
- ContributorDividend Stocks for the Wee...
- Contributor10 Dividend-Paying Stocks f...
- ContributorSpeaking Of Dividends 1-16-...
- ContributorCramer's Defensive Stocks W...
Latest ABT Headlines from TheStreet
- CMED Gets Wave of Health: China Watch
08.30.10 | 06:08 am - 6 Stocks With Dividends Beating Bond Yields 08.16.10 | 06:08 am
- Arena Pharma: Deja Vu Danger 08.09.10 | 07:08 am
- History Says August Will Be a Winner 08.04.10 | 08:08 am
- Stocks Under $5: Two Finds 08.01.10 | 03:08 pm
- Cramer: Don't Play a Rotation 07.29.10 | 03:07 pm
- Prescribing Medco 07.29.10 | 09:07 am
- Stocks Under $5: Two New Finds 07.29.10 | 06:07 am
- Verizon, AT&T Power Telecom ETFs 07.23.10 | 11:07 am
- Wells Fargo: Analysts' Upgrades, Downgrades 07.22.10 | 09:07 am
Press Releases for ABT
- Abbott Receives FDA Approval For First Automated Molecular Test For Assessing Hepatitis B Treatment - PR Newswire 09.01.10 | 10:09 am
- Abbott To Present At Morgan Stanley Global Healthcare Unplugged Conference - PR Newswire 08.30.10 | 08:08 am
- Abbott Launches New Psoriasisanswers.com Web Site - PR Newswire 08.12.10 | 09:08 am
- Abbott's SIMCOR ® ( Niacin Extended-release / Simvastatin ) Receives FDA Approval For New Dosage Strengths - PR Newswire 07.28.10 | 04:07 pm
- Abbott Fund-Sponsored Laboratory Training Initiative Helps Stem Critical Shortage Of Medical Professionals In California - PR Newswire 07.28.10 | 10:07 am
- Abbott To Feature Novel Tests And New Upgrades To Testing Platforms At American Association For Clinical Chemistry Lab Expo - PR Newswire 07.26.10 | 11:07 am
- Abbott To Present At Wedbush Securities Life Sciences Best Ideas MAC Conference - PR Newswire 07.22.10 | 08:07 am
- Abbott's PROGRESS Study Of Kaletra And Isentress Compared With A Standard HIV Regimen Meets The Pre-Specified Primary Efficacy Endpoint - PR Newswire 07.19.10 | 06:07 am
- Abbott Hosts Conference Call For Second-Quarter Earnings - PR Newswire 07.07.10 | 08:07 am
- Abbott Receives FDA Clearance For Molecular Diagnostic Test For Detection Of Chlamydia And Gonorrhea Infections - PR Newswire 06.28.10 | 09:06 am
Partner Headlines for ABT
- Portfolio Forensics - Seeking Alpha 08.31.10 | 09:08 am
- Repros Schedules Meeting with FDA - Analyst Blog - Zacks 08.26.10 | 10:08 am
- Six Large-Cap Dividend Achievers on Sale - Seeking Alpha 08.26.10 | 08:08 am
- UPDATE 1-Absolute Software posts Q4 loss on higher costs - Reuters 08.23.10 | 05:08 pm
- Eight Dividend Stocks Yielding More Than Fixed Income - Seeking Alpha 08.18.10 | 08:08 am
- 10 Stocks With a Sustainable Dividend Growth Rate - Seeking Alpha 08.11.10 | 08:08 am
- 360-Degree Diversification for Income Investors - Seeking Alpha 08.10.10 | 09:08 am
- FDA panel to review Abbott's Meridia on Sept. 15 - Reuters 08.06.10 | 01:08 pm
- Analyst Stock Picks With Liquidity, Growth and Yield - With Macro Caution - Seeking Alpha 08.02.10 | 06:08 am
- 16 Stocks That Saw Insider Buying Last Week - Seeking Alpha 08.02.10 | 04:08 am
